Astera Labs (NASDAQ: ALAB) posted $584.9M in Q3 FY2026 revenue, up 154% from $230.6M a year ago and 49% sequentially. The company cleared the $550.8M consensus by roughly $34M. Non-GAAP diluted EPS of $1.32 beat the $1.19 estimate, and the Q4 guide of $730M–$750M implies another quarter of roughly 25% sequential growth rather than consolidation.
The composition of the beat matters more than its size. Scorpio fabric switches became the company's largest product family by revenue, driven by volume production of the Scorpio X-Series 320-lane fabric switch. That is a mix shift with real consequences: Astera is no longer a signal-conditioning story with a switching option attached. The 320-lane switch is the highest-value, highest-complexity part of the rack-scale connectivity stack, and it now anchors the revenue base.
Margins tell the same story from a different angle. Non-GAAP gross margin came in at 72.4%, down from 76.4% a year ago and 73.7% last quarter. That 400bp year-over-year decline is the cost of the Scorpio ramp. Switch silicon carries more content and more complexity than retimers, and the company is absorbing the manufacturing and test burden of a product family that only recently reached high volume. GAAP gross margin of 72.3% tracks the non-GAAP figure closely, so this is not an accounting artifact. The guidance for Q4 holds gross margin at approximately 72%, which tells you management expects the mix drag to persist rather than reverse as Scorpio scales further.
Operating leverage offsets the gross margin compression. Non-GAAP operating margin reached 44.7%, up from 41.7% a year ago and 39.1% last quarter, as revenue growth outran opex. GAAP operating margin of 30.6% sits 1,410bp below the non-GAAP figure, almost entirely stock-based compensation of $82.6M, which is 14.1% of revenue. That gap is narrowing in percentage terms (it was 17.7% a year ago) but the absolute dollar figure is climbing fast: SBC rose 103% year over year. Investors who anchor on the non-GAAP number should note that the GAAP-to-non-GAAP bridge is widening in dollars even as it narrows as a percentage of a much larger revenue base.
The Q4 outlook is the most aggressive part of the release. Revenue of $730M–$750M would represent 25%–28% sequential growth on top of a quarter that already grew 49% sequentially. Non-GAAP EPS of $1.62–$1.66 compares with $1.32 in Q3, a 23%–25% step up. The company is guiding non-GAAP operating expenses of $194M–$200M, up from roughly $162M implied in Q3, so it is investing into the ramp rather than harvesting it. GAAP EPS guidance of $1.13–$1.17 sits well below the non-GAAP range, reflecting the $79M quarterly SBC charge embedded in the outlook.
The portfolio expansion reads as a hedge against concentration. Aries 7 extends the signal-conditioning franchise to PCIe 7 with optical and copper variants, sampling in Q4 2026. Leo 2 and Leo X-Series push into memory expansion and fabric-attached memory. Orion is a compute-agnostic rack-scale reference architecture aimed at neocloud and enterprise customers, with designs available through OEM and ODM partners starting Q1 2027. Each of these is a 2027 revenue story, not a 2026 one, but together they widen the addressable content per accelerator beyond the Scorpio switch alone.
The balance sheet shows the working capital cost of this growth. Accounts receivable rose to $284.3M from $83.2M at year-end 2025, and inventory climbed to $200.9M from $59.0M. Those are 3.4x increases respectively against nine-month revenue growth of 121%, so receivables and inventory are growing faster than sales. Some of that is prudent positioning ahead of a Q4 guide that implies another large sequential step, but it also means cash conversion will lag reported earnings. Operating cash flow of $341.5M over nine months against net income of $416.3M reflects exactly that drag.
The analytical question is whether the Q4 guide is demand-driven or backlog-driven. A 25% sequential guide on top of a 49% sequential quarter is unusual outside of genuine supply-constrained ramps, and the inventory build is consistent with the company pre-positioning for a known shipment schedule rather than responding to spot demand. If that read is right, the Q4 print should land near the middle or high end of the range, and the risk shifts to Q1 2027, when the Scorpio X-Series ramp annualizes and the Aries 7 and Orion contributions have not yet begun. The company has guided gross margin flat at 72%, which suggests management does not expect the mix to improve as new products layer in. Watch the Q1 guide for the first real test of whether this is a durable platform ramp or a concentrated deployment cycle.